EDAP Announces Preliminary Q4 Record Focal One System Sales And Placements; Company Reports Preliminary Placement Results Of Twelve Focal One Systems, Inclusive Of Ten Capital Sales
Portfolio Pulse from Benzinga Newsdesk
EDAP TMS SA (NASDAQ:EDAP) announced preliminary results for Q4 2023, reporting a record number of twelve Focal One Systems placements, including ten capital sales. The company also saw a record quarter for sales of ExactVu Micro-Ultrasound systems. The demand came from both academic medical centers and community hospitals. CEO Ryan Rhodes highlighted the momentum of the commercial team and the growing adoption of Focal One in prostate cancer management. Final Q4 financial results are expected in March.
January 08, 2024 | 1:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
EDAP TMS SA reported a record number of Focal One Systems placements and sales in Q4 2023, indicating strong demand for its products and potential revenue growth.
The record sales and placements of Focal One Systems suggest a positive revenue impact for EDAP, which could lead to an increase in investor confidence and a potential rise in stock price in the short term. The news is directly related to the company's performance and is likely to be seen as a positive development by investors. However, the final financial results are pending, which introduces some uncertainty.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100